von recklinghausen’s neurofibromatosis: presenting a case of vaginal neurofibroma and literature review
DOI:
https://doi.org/10.18597/rcog.194Keywords:
von Recklinghausen neurofibromatosis, vaginal tumour, café-au-lait spotsAbstract
Objective: Reviewing manifestations of neurofibromatosis presenting in the genital region, their differential diagnosis and managing lesions.
Materials and methods: The case of a 63-year-old patient admitted to the Suba hospital’s colposcopy and pathology of the lower genital tract service due to having a mass in the genital region is presented; the hospital is a second level complexity public institution in Bogotá, Colombia, dealing with a subsidised regime population. Physical examination revealed café-au-lait spots and lesions compatible with neurofibroma, thereby orientating diagnosis towards neurofibromatosis type 1. A systematic search was made of the literature in Medline-Pubmed, using the MeSH terms: neurofibromatosis, von Recklinghausen’s disease, vagina, genital tract, pelvic tumour. A clinical case and review of the topic are presented.
Results: 7,991 publications related to neurofibromatosis were found. Just 30 of them were related to pelvic lesions and the genitourinary tract and only 6 case reports and one case series dealt with lesions located in the lower genital tract; 12 articles reviewing the topic were selected for a description of the diagnostic generalities and criteria. Differential diagnosis included schwannoma, neuroma, myxoma, leiomyoma and fibroepithelial polyp.
Conclusions: A neurofibroma being identified in the genitourinary tract is an infrequently occurring event, constituting a topic of interest for gynaecologists, paediatricians and urologists as it represents a diagnostic challenge.
Author Biographies
Luz Marcela Celis-Amórtegui
Camilo Andrés Romero-Hernández
Médico neurólogo, Departamento de Neurología Fundación Cardio-Infantil y Clínica del Country, Bogotá, Colombia.
Liliana Marcela Hernández-Gordillo
Johana Andrea Botero-Hernández
References
Ferner RE. The Neurofibromatoses. Pract Neurol 2010;10:82-93.
Shah KN. The Diagnostic and Clinical Significance of Café-au-lait macules. Pediatr Clin North Am 2010;57:1131-53.
Rose PT. Pigmentary disorders. Med Clin North Am 2009;93:1225-39.
Chao-Chun Y, Happle R. Giant Café-au-lait macule in neurofibromatosis 1: A type 2 segmental manifestation of neurofibromatosis 1? J Am Acad Dermatol 2008;58:493-7.
Pascual I, Lopez P, Savasta S, Lopez JC, Lago CM, Cisternino M et al. Neurofibromatosis type 1 with external genitalia involvement presentation of 4 patients. J Pediatr Surg 2008;43:1998-2003.
Rodriguez A, Truskinovsky A. Malignant peripheral nerve sheat tumor of the uterine cervix treated with vaginal trachelectomy. Gynecol Oncol 2006;100: 201-4.
Sharma JB, Wadhwa L, Malhotra M, Arora R, Garg A, Singh S. Huge localized vaginal neurofibromatosis: An unusual cause of postmenopausal bleeding. J Obstet Gynaecol Res 2004;30:96-9.
Kluger N, Perrochia H, Guillot B. Pelvic mass in von Reklinghausen’s neurofibromatosis: diagnostic issues: a case report. Cases J 2009;2:191.
Protopapas A, Sotiropoulou M, Haidopoulos D, Athanasiou S, Loutradis D, Antsaklis A. Ovarian neurofibroma: a rare visceral occurrence of type 1 neurofibromatosis and an unusual cause of chronic pelvic pain. J Minim Invasive Gynecol 2011;18:520-4.
Ou KY, Kan YY. A dangling development. Am J Obstet Gynecol 2008;198:482.e1.
Rallis E, Ragiadakou D. Giant plexiform neurofibroma in a patient with neurofibromatosis type 1. Dermatol Online J 2009;15:7.
Lytras A. Reproductive disturbances in multiple neuroendocrine tumor syndromes. Endocr Relat Cancer 2009;16:1125-38.
Ceccaroni M, Genuardi M, Legge F, Lucci-Cordisco E, Carrara S, D’Amico F et al. BCRA-1 related malignancies in a family presenting with von Rechlinhausen‘s disease. Gynecol Oncol 2002;86:375-8.
Lodish M, Stratakis A. Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes. Best Pract Res Clin Endocrinol Metab 2010;24:439-49.
Brems H, Beert E, De Ravel T, Legius E. Mechanism in pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 2009;10:508-15.
Neurofibromatosis: Conference statement. Arch Neurol 1988;45:575-8.
Radtke H, Sebold C, Allison C, Haidle JL, Schneider G. Neurofibromatosis type 1 in Genetic Counseling Practice: Recommendations of the National Society of Genetic Counselors. J Genet Counsel 2007;16: 387-407.
Solomon SB, Semih A, Nicol TL, Campbell JN, Pomper MG. Possitron emission tomography in the detection and management of sarcoumatous transformation in neurofibromatosis. Clin Nucl Med 2001;26:525-8.
Parsons CM, Canter RJ, Khatri VP. Surgical Management of Neurofibromatosis. Surg Oncol Clin N Am 2009;18:175-96.
Maruta H. Effective neurofibromatosis therapeutics blocking the oncogenic kinase PAK1. Drug Discov Ther 2011;5:266-78.
How to Cite
Downloads
Downloads
Published
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
